AU4270896A - Vaccine against aids comprising a peptide sequence of hiv - Google Patents

Vaccine against aids comprising a peptide sequence of hiv

Info

Publication number
AU4270896A
AU4270896A AU42708/96A AU4270896A AU4270896A AU 4270896 A AU4270896 A AU 4270896A AU 42708/96 A AU42708/96 A AU 42708/96A AU 4270896 A AU4270896 A AU 4270896A AU 4270896 A AU4270896 A AU 4270896A
Authority
AU
Australia
Prior art keywords
hiv
peptide sequence
vaccine against
against aids
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42708/96A
Inventor
Frances Gotch
Andrew James Mcmichael
Sarah Rowland-Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU4270896A publication Critical patent/AU4270896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU42708/96A 1994-12-23 1995-12-21 Vaccine against aids comprising a peptide sequence of hiv Abandoned AU4270896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9426153.4A GB9426153D0 (en) 1994-12-23 1994-12-23 Improvements in or relating to vaccines
GB9426153 1994-12-23
PCT/GB1995/003009 WO1996020006A1 (en) 1994-12-23 1995-12-21 Vaccine against aids comprising a peptide sequence of hiv

Publications (1)

Publication Number Publication Date
AU4270896A true AU4270896A (en) 1996-07-19

Family

ID=10766540

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42708/96A Abandoned AU4270896A (en) 1994-12-23 1995-12-21 Vaccine against aids comprising a peptide sequence of hiv

Country Status (3)

Country Link
AU (1) AU4270896A (en)
GB (1) GB9426153D0 (en)
WO (1) WO1996020006A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2833425C (en) * 2011-04-07 2018-08-21 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Protease cleavage site peptides as an hiv vaccine
EP2745845A1 (en) 2012-12-19 2014-06-25 Centre Hospitalier Universitaire de Bordeaux A method for preventing or treating an HIV infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
GB8918200D0 (en) * 1989-08-09 1989-09-20 Medical Res Council The peptide fragments of hiv
WO1992021376A1 (en) * 1991-06-06 1992-12-10 Med Immune, Inc. Induction of ctl responses to foreign antigens expressed in mycobacteria

Also Published As

Publication number Publication date
WO1996020006A1 (en) 1996-07-04
GB9426153D0 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
AU4878096A (en) Hepatitis b vaccine
AU5726694A (en) Human immunodeficiency virus decoy
AU1308495A (en) Influenza vaccine
AU6304996A (en) Vaccines against hepatitis c
AU2469092A (en) Anti-hiv (aids) agents
CZ197595A3 (en) Vaccine preparations
HUP9601466A2 (en) Adjuvants for viral vaccines
AU4450093A (en) Hepatitis A virus vaccine
AU8900691A (en) Hiv marker/aids vaccine
AU3154395A (en) Contraceptive vaccine
AU5848794A (en) Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
AU2769595A (en) Contraceptive vaccine
AU7465696A (en) Synthetic vaccine for protection against human immunodeficiency virus infection
AU6820796A (en) Antigenic preparations
AU6715094A (en) Recombinant vaccine
AU4450696A (en) Enhanced immunogenic vaccine
AU5851296A (en) Malaria peptides and vaccines
AU6161794A (en) Peptides having anti-hiv activity
AU3552797A (en) Vaccine preparations
AU4270896A (en) Vaccine against aids comprising a peptide sequence of hiv
AUPN023894A0 (en) A surgical aid
AU3536895A (en) A new human peptide antibiotic (fall-39) and its use
AU1464395A (en) A hairstyling aid
AU1194997A (en) Plasmid vaccine against pseudorabies virus
AU5520796A (en) Peptide-based vaccine against papillomavirus infection